Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Smith & Nephew PLC's Subsidiary To Acquire Healthpoint Biotherapeutics


Wednesday, 28 Nov 2012 02:00am EST 

Smith & Nephew PLC announced that it has entered into an agreement through its subsidiaries to acquire substantially all the assets of Healthpoint Biotherapeutics, company into in bioactive debridement, dermal repair and regeneration wound care treatments, for $782 million in cash. 

Company Quote

87.21
-0.88 -1.00%
22 Aug 2014